Skip to main content

Saint Therapeutics Founder and CMO Dr. C...

  Saint Therapeutics Founder and CMO Dr. Chia Soo Speaks on Space Medicine and Regenerative Healing at PSRC 2026 Jun 08, 2026   Saint Therapeutics is pleased to share that Chia Soo, MD, FACS, Founder and Chief Medical Officer of Saint Therapeutics, participated in the UCLA Local Program at the Plastic Surgery Research Council Annual […]

Saint Therapeutics Publishes Study on No...

  Saint Therapeutics Publishes Study on Novel Wound Healing Treatment May 28, 2026   Millions of patients worldwide still suffer from poor wound healing and scar formation—areas where significant unmet medical needs remain. Better healing and reduced scarring could meaningfully improve the quality of life for millions of patients worldwide. We are proud to share that […]

Scarless Laboratories Announces Positive...

  Scarless Laboratories Announces Positive Results from its Phase 1/2a Clinical Study in Scar Reduction xxxx xx, 2025   Los Angeles, California–Scarless Laboratories, Inc., a biotechnology company with a platform technology in scar reduction and wound healing, announced today that it has completed its First-in-Human Phase 1/2a clinical study for improvement in scar appearance and wound […]

ADA Forsyth Fridays: Molecule may reduce...

  ADA Forsyth Fridays: Molecule may reduce scarring after orofacial cleft surgery Peptide drug derived from fibromodulin could be used in surgical procedures by Mary Beth Versaci  May 30, 2025   Researchers from the ADA Forsyth Institute and the University of California, Los Angeles have identified a molecule that may help reduce excessive scarring after orofacial cleft […]

Novel therapeutic approach could elimina...

  Novel therapeutic approach could eliminate excessive scarring following orofacial cleft repair Skylar Rolstad May 9, 2025 Posted in News, Research NewsTags:Craniofacial Biology Novel therapeutic approach could eliminate excessive scarring following orofacial cleft repair   Somerville, Mass., 05/07/2025 – Cleft lip and/or cleft palate are among the most common craniofacial birth defects in the United […]

Newly identified protein could mitigate ...

  Newly identified protein could mitigate oreliminate excessive scarring during woundhealing May 6 2025 Fibromodulin (FMOD) accelerates myofibroblast clearance in rat and pig models with reduced scar formation. Credit: Nature Communications (2025). DOI:10.1038/s41467-025-58906-z   A study published April 12 in Nature Communications identifies a protein that helps prevent excessive scarring. The protein, called fibromodulin (FMOD) forms […]

Researchers may have found a way to miti...

  Researchers may have found a way to mitigate or eliminate excessive scarring during wound healing Medical Services▸Surgery▸Plastic Surgery UCLA Health News Release May-5-2025 https://www.uclahealth.org/news/release/researchers-may-have-found-way-mitigate-or-eliminate     FINDINGS A study published April 12 in Nature Communications identifies a protein that helps prevent excessive scarring. The protein, called fibromodulin (FMOD) forms a complex of molecules with […]

Researchers may have found a way to miti...

  Researchers may have found a way to mitigate or eliminate excessive scarring during wound healing EurekAlert!▸Peer-Reviewed Publication University of California – Los Angeles Health Sciences News Release 30-Apr-2025 https://www.eurekalert.org/news-releases/1082760     FINDINGS A study published April 12 in Nature Communications identifies a protein that helps prevent excessive scarring. The protein, called fibromodulin (FMOD) forms […]